11 min reading time

Stool Tests for SIBO: Technologies, Markers, and Mechanisms

Let’s be clear from the start: While stool tests are incredibly useful in determining what is wrong in your intestines, a stool test cannot directly diagnose small intestinal bacterial overgrowth (SIBO). This is a frequent point of confusion for individuals seeking information about their digestive health. SIBO occurs when an unusually high number of bacteria accumulate in the small intestine, which is the upper section of the digestive tract. A stool sample consists of waste formed at the very end of the digestive tract in the large intestine. Because of this anatomical distance, a stool test evaluates the environment of the large intestine rather than the small intestine¹.
Despite this physical separation, medical professionals and functional health practitioners frequently order stool tests for individuals suspected of having SIBO. Breath tests and stool tests answer different questions. A breath test measures the gases produced by bacteria specifically in the small intestine. A stool test measures biological markers that reveal the underlying causes of bacterial overgrowth and the physical damage the overgrowth leaves behind².
This report explains the specific types of stool tests used in SIBO evaluations, the exact biological markers they measure, and the physical mechanisms behind those markers.

Laboratory Technologies for Stool Analysis

When practitioners investigate SIBO, they rarely order a single, isolated stool test. Instead, they order comprehensive stool panels. Common examples of these panels include the GI-MAP by Diagnostic Solutions, the GI360 by Doctor’s Data, and the GI Effects Comprehensive Profile by Genova Diagnostics⁴.
These comprehensive panels are different from the standard stool cultures performed in a typical hospital laboratory. Older culture methods require technicians to place a stool sample in a petri dish to see what bacteria grow². Many microbes living in the human gut are anaerobic, meaning they die when exposed to oxygen. This makes them difficult to grow in a standard laboratory environment⁵.
To solve this problem, comprehensive stool tests use DNA analysis. They bypass the need to keep the bacteria alive.

Polymerase Chain Reaction and Metagenomics

Modern stool tests use a technique called polymerase chain reaction (PCR). PCR technology looks for the genetic fingerprints of specific microorganisms². This allows the laboratory to detect specific bacteria, yeasts, and parasites that a standard culture might miss.
A 2025 international consensus statement published in The Lancet Gastroenterology & Hepatology clarified how these DNA tests work. The consensus statement noted that PCR is highly targeted for finding known organisms, but it does not map the entire bacterial community. To see the full microbiome profile, laboratories use broader genetic sequencing methods, such as shotgun metagenomics or 16S rRNA gene sequencing². These advanced technologies read the genetic code of everything in the stool sample, providing a detailed map of the gut ecosystem.

The Mechanics of DNA Extraction

Extracting accurate DNA data from a stool sample requires specific laboratory techniques. The stool matrix is physically complex. It contains undigested food, metabolic waste, and thick mucus.
To test the DNA of the microbes, the laboratory must break open the outer cellular walls of the bacteria. Some bacteria have incredibly tough cell walls that resist standard chemical breakdown. To extract the DNA, laboratories use a mechanical process called bead beating⁸.
During bead beating, technicians place the stool sample in a tube filled with microscopic beads. A machine vigorously shakes the tube. The physical impact of the beads fractures the tough bacterial walls, releasing the DNA into the testing liquid⁸. If a laboratory uses a weak extraction method without bead beating, they fail to break open the toughest bacteria. This biases the final report. It makes it appear as though the patient has low amounts of certain bacteria simply because those bacteria were never broken open and counted⁹.

Measuring Methane-Producing Organisms

One of the most specific stool tests used alongside SIBO evaluations involves measuring an organism called Methanobrevibacter smithii (M. smithii).
SIBO is categorized by the type of gas the overgrown organisms produce. One major category was traditionally called methane-dominant SIBO. Medical guidelines updated this name to intestinal methanogen overgrowth (IMO) because M. smithii is not a bacterium. It is an archaeon, which belongs to a completely different branch of microscopic life¹⁰.
M. smithii has a highly specialized job in the human gut. It consumes the hydrogen gas produced by other bacteria and combines it with carbon dioxide to generate methane gas¹⁰. Methane gas directly alters how the digestive tract moves. It acts on the intestinal muscles and slows down their contractions. This slowed movement leads to severe constipation¹.

Correlating Stool Counts with Breath Tests

The M. smithii stool test uses quantitative PCR technology to count the exact number of copies of this organism present in one gram of stool.
This stool measurement correlates highly with the results of a methane breath test¹⁰. Research shows that individuals with constipation-predominant digestive issues consistently have much higher counts of M. smithii in their stool than healthy individuals¹⁰. A stool concentration approaching one million (10^6) copies per gram strongly indicates that methane production is slowing down the person’s digestive transit¹⁰.
The stool test provides a structural measurement by showing how many organisms are physically present. The breath test provides a functional measurement by showing how much gas they are actively producing. Practitioners often pair the two tests to confirm an IMO diagnosis and track treatment progress¹⁰.

Digestive Enzyme Markers

An overgrowth of bacteria in the small intestine disrupts the normal breakdown and absorption of food. Comprehensive stool tests measure specific chemicals to evaluate how well the stomach, pancreas, and liver function.

Fecal Elastase-1

Fecal elastase-1 is a protein enzyme produced by the pancreas. The pancreas releases elastase into the small intestine to help digest food. Unlike other digestive enzymes that break down as they move through the digestive tract, elastase-1 remains highly stable. It passes all the way through the intestines and exits the body in the stool¹⁴.
A stool test measures the concentration of this enzyme to check for exocrine pancreatic insufficiency (PEI). Normal elastase levels are above 500 micrograms per gram (μg/g) of stool. Levels between 200 and 500 μg/g indicate a mild to moderate decrease in function. Levels below 100 μg/g indicate severe pancreatic insufficiency¹⁴.
When the pancreas does not produce enough digestive enzymes, large food particles remain undigested in the small intestine. Bacteria feed on these undigested particles. This excess food supply allows the bacteria to multiply rapidly, which can trigger or worsen SIBO⁴.

The Dilution Problem in Elastase Testing

There is a known mechanical complication with fecal elastase-1 testing in patients with SIBO. SIBO frequently causes watery diarrhea. When a stool sample contains excess water, the liquid dilutes the concentration of the elastase enzyme¹⁴.
This dilution causes the laboratory result to show a falsely low elastase level. The test report might indicate that the pancreas is failing when it is actually functioning normally. To prevent this false positive, specific laboratories use a process called lyophilization. They freeze-dry the stool sample to remove all the water before measuring the elastase levels¹⁴. Alternatively, they use a centrifuge to spin the water out of the sample. To get the most accurate result, the elastase test must ideally be performed on formed, solid stool¹⁸.

Fat Malabsorption and Bile Acid Markers

A stool test can quantify the amount of fat leaving the body. Normally, the small intestine absorbs almost all dietary fat. SIBO interferes with this process through a specific chemical reaction involving bile.
The liver produces bile salts, which act like dish soap to break down dietary fats so the body can absorb them. When there are too many bacteria in the small intestine, those bacteria prematurely break apart the bile salts. This process is called deconjugation²¹.
Without intact bile salts, the dietary fats cannot be absorbed. The unabsorbed fat travels into the large intestine and exits in the stool. This condition is called steatorrhea²¹.

Measuring Fecal Fat

A steatocrit measurement, or a 72-hour fecal fat test, reveals whether this malabsorption is happening. The patient collects their stool for three days while eating a specific diet. The laboratory then measures the exact weight of the fat in the stool. Excreting more than 7 grams of fat per day is considered abnormal²¹. High levels of fat in a stool test often signal that SIBO bacteria are actively deconjugating bile salts higher up in the digestive tract²¹.

Bile Acid Diarrhea

If the bile salts are not properly absorbed in the small intestine, they spill over into the colon. Bile acids irritate the lining of the large intestine. They stimulate the colon to release water and electrolytes, which causes severe, watery diarrhea²⁴. This condition is known as bile acid diarrhea (BAD). Specific stool tests can measure the total amount of fecal bile acids to see if they are the root cause of the patient’s symptoms²⁵.

Markers of Inflammation and Immune Activity

SIBO causes physical stress on the lining of the digestive tract. Over time, the constant presence of excess bacteria and their waste products damages the intestinal walls. Stool tests measure proteins related to the immune system to assess this damage.

Fecal Calprotectin

Calprotectin is a protein found inside neutrophils, which are a type of white blood cell. When there is active inflammation in the digestive tract, the immune system sends neutrophils to the intestinal lining to fight the perceived threat. These white blood cells release calprotectin, which then accumulates in the stool²⁶.
This specific stool marker is primarily used to separate SIBO and irritable bowel syndrome (IBS) from more severe inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis²⁷.
SIBO and IBS do not typically cause massive immune cell responses in the intestinal lining. Therefore, a person with SIBO will generally have normal or only slightly elevated fecal calprotectin levels, usually below 50 micrograms per gram²⁵. If a stool test reveals extremely high calprotectin levels, it indicates serious tissue inflammation that requires a different medical investigation, such as a colonoscopy¹⁶.

Intestinal Permeability Markers

Zonulin is a protein that regulates the physical connections between the cells that line the intestines. These connections are called tight junctions. Under normal conditions, tight junctions stay closed to prevent large food proteins, bacteria, and toxins from leaking out of the intestines and into the bloodstream.
When the intestinal lining is exposed to harmful bacteria or chronic inflammation, the body releases excess zonulin. High zonulin levels force the tight junctions to open. This structural breakdown is known medically as increased intestinal permeability, and it is known colloquially as “leaky gut”²⁹.
A stool test measures the concentration of zonulin. Elevated fecal zonulin shows that the intestinal barrier is compromised. SIBO is a known trigger for this barrier damage⁴. The excess bacteria produce waste products that continually irritate the intestinal lining, prompting the release of zonulin.

The Zonulin Testing Controversy

There is ongoing debate within the scientific community regarding commercial zonulin stool tests. Researchers publishing in the medical journal Gut, including Massier and Fasano, noted that the laboratory methods used to measure zonulin might lack exact specificity²⁹.
These tests use a technology called an ELISA assay. The researchers discovered that some commercial ELISA assays might accidentally attach to and measure other similar proteins in the stool, rather than just zonulin²⁹. Because of this, a high zonulin score on a stool test might reflect a general disruption in the gut rather than an exact count of the zonulin protein. Despite this debate, many functional practitioners rely on fecal zonulin levels as a baseline metric to track whether the gut barrier is healing after SIBO treatments²⁹.

Metabolic Byproducts and Physical Consistency

Bacteria in the digestive tract survive by fermenting the carbohydrates and fibers that humans cannot digest. This fermentation process produces metabolic byproducts that alter the chemistry of the stool.

Short-Chain Fatty Acids and Organic Acids

When bacteria ferment fiber, they produce short-chain fatty acids (SCFAs). The three main SCFAs are butyrate, propionate, and acetate²². These fatty acids are usually beneficial, as they provide energy for the cells lining the colon.
However, in cases of severe bacterial overgrowth, the bacteria can produce excessive amounts of these acids. A stool test measures the exact concentration of SCFAs and other organic acids. A massive increase in these acids lowers the pH of the stool, making it highly acidic³⁴. An unusually low stool pH, dropping near 4.0, suggests that carbohydrates are not being absorbed properly in the small intestine and are instead being rapidly fermented by bacteria³⁴.

The Bristol Stool Scale

Comprehensive stool testing also involves a physical grading of the stool’s consistency using the Bristol Stool Scale. The scale rates stool from Type 1 (hard, separate lumps) to Type 7 (entirely liquid)³⁵.
The physical consistency of the stool correlates directly with intestinal transit time. It also correlates with the physical density of the bacteria inside the gut. Research shows that a faster transit time (Type 6 or 7 liquid stools) is linked to an increased abundance of fast-growing bacterial species. The bacteria replicate rapidly to avoid being washed out of the digestive tract by the diarrhea³⁶. A doctor uses the Bristol Stool Scale alongside the biochemical markers to categorize the patient’s symptoms as diarrhea-predominant or constipation-predominant¹².

Summary of Stool Markers in SIBO Evaluations

The specific chemicals and genetic markers found in stool samples provide different pieces of evidence regarding a person’s digestive function.

Stool Marker	Testing Method	Connection to SIBO and Gut Health
Bacterial DNA	PCR or Metagenomic Sequencing	Identifies specific bacteria and archaea living in the large intestine.
M. smithii	Quantitative PCR	High counts correlate with methane breath tests and severe constipation.
Fecal Elastase-1	Protein Assay	Low levels indicate pancreatic failure; leaves undigested food in the gut.
Fecal Fat	72-Hour Collection (Steatocrit)	High levels indicate SIBO bacteria are destroying bile salts needed for fat absorption.
Fecal Calprotectin	Protein Assay	Normal levels help confirm SIBO; high levels point toward Inflammatory Bowel Disease.
Fecal Zonulin	ELISA Assay	High levels indicate tight junction damage (leaky gut) caused by bacterial irritation.
Short-Chain Fatty Acids	Organic Acid Screening	Abnormal levels reveal rapid carbohydrate fermentation and altered stool pH.

A stool test remains a tool for gathering secondary evidence. It maps the biological damage, the immune response, and the digestive failures that occur downstream from the small intestine. Practitioners combine these structural clues with breath tests to build a complete view of a patient’s gastrointestinal health.

Works Cited & Scientific References 36

▼

Topics & Tags: